Colon cancer is the third most common cancer in the United States, and thanks to improved screening and treatment, survival rates have improved significantly in recent years. If you're a colorectal cancer survivor, you may be wondering whether life insurance is still within reach. The answer depends on your stage, treatment, and how long ago you completed treatment — but for many survivors, coverage is absolutely possible.

How Insurers Evaluate Colon Cancer

Life insurance underwriters assess colon (colorectal) cancer based on several factors that reflect your long-term survival risk:

  • Stage at diagnosis — The most important factor. Stage I and early Stage II cases are viewed most favorably. Stage III is more complex but insurable after sufficient time. Stage IV is typically uninsurable with standard coverage.
  • Surgical outcome — Whether surgical margins were clear matters to underwriters. Complete resection with no residual cancer is the strongest possible outcome.
  • CEA levels — Carcinoembryonic antigen is a tumor marker used to monitor recurrence. Normal CEA levels post-treatment significantly improve your application.
  • Lymph node involvement — No positive lymph nodes (Stage I/II) is considerably more favorable than cases with nodal involvement (Stage III).
  • Treatment type — Surgery alone indicates early-stage disease. Chemotherapy indicates Stage III or higher and requires a longer waiting period.
  • Time since treatment — The longer you've been cancer-free with clean surveillance, the better your rates and options.
  • Colonoscopy surveillance results — Clean follow-up colonoscopies are strong evidence that recurrence hasn't occurred.

Waiting Periods and Rate Expectations by Stage

Stage I

One of the most favorable cancer diagnoses for life insurance purposes. Many insurers will consider applications 12–24 months after treatment completion. A flat extra charge (typically $500–$750 per $100,000 of coverage) may apply for the first few years. After 3–5 years cancer-free, standard rates are often achievable.

Stage II

Waiting periods typically run 2–5 years depending on the substage and whether any complications occurred. Table ratings of Table 2–4 are common in the early years post-treatment. After 5+ years with clean surveillance, rates improve substantially.

Stage III

This stage involves lymph node spread and typically requires chemotherapy. Most insurers require a waiting period of 5+ years after treatment completion. Table ratings are higher, and some carriers may decline. After 7–10 years cancer-free, more options open up.

Stage IV (Metastatic)

Standard life insurance is generally unavailable for active or recently treated Stage IV colon cancer. Guaranteed issue policies with limited coverage ($5,000–$25,000) and a 2-year graded benefit period are typically the only option.

What If You Had Colon Polyps Removed?

If you had polyps removed during a colonoscopy and the pathology showed they were benign (non-cancerous), this typically has little to no effect on your life insurance application. Adenomatous polyps (which have cancer potential) may prompt some underwriters to ask follow-up questions, but a clean post-polypectomy colonoscopy is generally sufficient to proceed with standard underwriting.

If the removed polyp was cancerous, your application will follow standard colon cancer underwriting rules based on the pathology findings.

Lynch Syndrome and Hereditary Colorectal Cancer

If you've been diagnosed with Lynch syndrome — a hereditary condition that significantly increases colorectal and other cancer risks — this will affect your underwriting even if you've had successful treatment. Insurers may apply higher ratings or decline coverage depending on your carrier. An independent broker who specializes in high-risk cases is particularly valuable here, as underwriting guidelines vary considerably between carriers.

How to Strengthen Your Application

  • Compile your medical records. Pathology reports, surgical notes, chemotherapy records (if applicable), CEA test results, and colonoscopy reports all help underwriters evaluate your case accurately.
  • Stay current with surveillance. Regular colonoscopies on the recommended schedule — and clean results — demonstrate that you're monitoring your health proactively and that recurrence hasn't occurred.
  • Maintain excellent overall health. A healthy weight, non-smoker status, good blood pressure, and no other major health conditions partially offset the cancer history in underwriting.
  • Work with an independent broker. Colon cancer underwriting varies significantly between carriers. Some are considerably more favorable than others for specific stages and time periods. Shopping with one company directly means you're likely leaving better options on the table.
  • Be honest about your history. Full disclosure is essential. Concealing cancer history can result in a denied claim for your family.

Alternatives If Standard Coverage Isn't Available Yet

  • Guaranteed issue life insurance — No medical questions, anyone qualifies. Coverage is limited (typically $5,000–$25,000) and has a 2-year waiting period before full benefits apply. Suitable as a temporary bridge while you wait out the standard underwriting period.
  • Simplified issue life insurance — Fewer health questions, no exam, coverage up to $500K with some carriers. A practical option if you're within 3–5 years of treatment and still facing table ratings on fully underwritten policies.
  • Group life insurance through your employer — Most employer-sponsored group life insurance doesn't require medical underwriting. If this benefit is available to you, maximize it. It's often your best option during the early years after treatment.

How Much Coverage Do You Need?

Your coverage needs are based on your financial situation — income, debts, dependents — not your health history. Use our Life Insurance Calculator to estimate the right amount for your circumstances.

Bottom Line

Colon cancer survivors — especially those diagnosed at Stage I or II — have solid life insurance options, particularly after several years of clean follow-up. Stage III survivors have fewer immediate options but can expect improved access as time passes. The most important steps are staying current with your surveillance, working with a broker who understands cancer underwriting, and not assuming you'll be denied before you've actually shopped around.